Coronavirus-19 disease risk and protective factors associated with HLA/KIR polymorphisms in Ecuadorian patients residing in Madrid
出版年份 2023 全文链接
标题
Coronavirus-19 disease risk and protective factors associated with HLA/KIR polymorphisms in Ecuadorian patients residing in Madrid
作者
关键词
-
出版物
HUMAN IMMUNOLOGY
Volume 84, Issue 11, Pages 571-577
出版商
Elsevier BV
发表日期
2023-09-29
DOI
10.1016/j.humimm.2023.09.004
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- HLA-C*04:01 Affects HLA Class I Heterozygosity and Predicted Affinity to SARS-CoV-2 Peptides, and in Combination With Age and Sex of Armenian Patients Contributes to COVID-19 Severity
- (2022) Anahit Hovhannisyan et al. Frontiers in Immunology
- Individualized Constellation of Killer Cell Immunoglobulin-Like Receptors and Cognate HLA Class I Ligands that Controls Natural Killer Cell Antiviral Immunity Predisposes COVID-19
- (2022) Stalinraja Maruthamuthu et al. Frontiers in Genetics
- HLA variation and antigen presentation in COVID-19 and SARS-CoV-2 infection
- (2022) Danillo G Augusto et al. CURRENT OPINION IN IMMUNOLOGY
- NK cells - Dr. Jekyll and Mr. Hyde in autoimmune rheumatic diseases
- (2022) Tahereh Hojjatipour et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Association between HLA-C alleles and COVID-19 severity in a pilot study with a Spanish Mediterranean Caucasian cohort
- (2022) Lorena Vigón et al. PLoS One
- In-silico study of influence of HLA heterogeneity on CTL responses across ethnicities to SARS-CoV-2
- (2022) Vishal Rao et al. HUMAN IMMUNOLOGY
- HLA-B evolutionary divergence is associated with outcomes after SARS-CoV-2 infection
- (2022) Patricia V. Hernandez et al. HUMAN IMMUNOLOGY
- Relationship between KIR genotypes and HLA- ligands with SARS-CoV-2 infection in the Saudi population
- (2022) Suliman Alomar et al. JOURNAL OF KING SAUD UNIVERSITY SCIENCE
- The IPD-IMGT/HLA Database
- (2022) Dominic J Barker et al. NUCLEIC ACIDS RESEARCH
- Activating Killer-cell Immunoglobulin-like Receptors are associated with the severity of COVID-19
- (2021) Enrique Bernal et al. JOURNAL OF INFECTIOUS DISEASES
- Presenting characteristics and outcomes of migrants in a cohort of hospitalized patients with COVID-19: Does the origin matter?
- (2021) Marta Díaz-Menéndez et al. Travel Medicine and Infectious Disease
- The influence of HLA genotype on the severity of COVID‐19 infection
- (2021) David J. Langton et al. HLA
- Association of KIR gene polymorphisms with COVID-19 disease
- (2021) Ali Hajeer et al. CLINICAL IMMUNOLOGY
- Functional exhaustion of antiviral lymphocytes in COVID-19 patients
- (2020) Meijuan Zheng et al. Cellular & Molecular Immunology
- Natural killer cell receptor variants and chronic hepatitis B virus infection in the Vietnamese population
- (2020) Eduardo Delabio Auer et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Human leukocyte antigen susceptibility map for SARS-CoV-2
- (2020) Austin Nguyen et al. JOURNAL OF VIROLOGY
- Viral and host factors related to the clinical outcome of COVID-19
- (2020) Xiaonan Zhang et al. NATURE
- Binding affinities of 438 HLA proteins to complete proteomes of seven pandemic viruses and distributions of strongest and weakest HLA peptide binders in populations worldwide
- (2020) Rodrigo Barquera et al. HLA
- A minimal common outcome measure set for COVID-19 clinical research
- (2020) John C Marshall et al. LANCET INFECTIOUS DISEASES
- HLA genetic polymorphisms and prognosis of patients with COVID-19
- (2020) L. Lorente et al. Medicina Intensiva
- Dynamic Natural Killer Cell and T Cell Responses to Influenza Infection
- (2020) Kayla Frank et al. Frontiers in Cellular and Infection Microbiology
- Racial and Ethnic Disparities in COVID-19–Related Infections, Hospitalizations, and Deaths
- (2020) Katherine Mackey et al. ANNALS OF INTERNAL MEDICINE
- Population Difference in Allele Frequency of HLA-C*05 and Its Correlation with COVID-19 Mortality
- (2020) Atsushi Sakuraba et al. Viruses-Basel
- The Clinical Features of Patients with Chronic Hepatitis C Virus Infections Are Associated with Killer Cell Immunoglobulin-Like Receptor Genes and Their Expression on the Surface of Natural Killer Cells
- (2018) Ariel Podhorzer et al. Frontiers in Immunology
- Diversity of Killer Cell Immunoglobulin-Like Receptors and Disease
- (2018) Raja Rajalingam CLINICS IN LABORATORY MEDICINE
- Natural killer cells contribute to hepatic injury and help in viral persistence during progression of hepatitis B e-antigen-negative chronic hepatitis B virus infection
- (2016) S. Ghosh et al. CLINICAL MICROBIOLOGY AND INFECTION
- The HLA-C*04
- (2015) Alex Olvera et al. AIDS
- KIR2DS4 Promotes HIV-1 Pathogenesis: New Evidence from Analyses of Immunogenetic Data and Natural Killer Cell Function
- (2014) Aimee M. Merino et al. PLoS One
- Control of Human Viral Infections by Natural Killer Cells
- (2013) Stephanie Jost et al. Annual Review of Immunology
- NK cells exacerbate the pathology of influenza virus infection in mice
- (2013) Gang Zhou et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Absence of activating killer immunoglobulin-like receptor genes combined with hepatitis C viral genotype is predictive of hepatocellular carcinoma
- (2013) Roberto Littera et al. HUMAN IMMUNOLOGY
- Immunogenetics of HIV disease
- (2013) Maureen P. Martin et al. IMMUNOLOGICAL REVIEWS
- Natural Killer Cell Responses to Viral Infection
- (2011) Joshua D. Brandstadter et al. Journal of Innate Immunity
- Natural Killer Cells Are Involved in Acute Lung Immune Injury Caused by Respiratory Syncytial Virus Infection
- (2011) F. Li et al. JOURNAL OF VIROLOGY
- Enrichment of Variations in KIR3DL1/S1 and KIR2DL2/L3 among H1N1/09 ICU Patients: An Exploratory Study
- (2011) David La et al. PLoS One
- Allelic and haplotypic HLA frequency distribution in Spanish hematopoietic patients. Implications for unrelated donor searching
- (2010) A. Balas et al. TISSUE ANTIGENS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started